Predictions
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€70.57
27.10.18
27.10.18
€132.40
08.11.18
08.11.18
-6.88%
08.11.18
08.11.18
Scotts Miracle-Gro Co. A
Start price
Target price
Perf. (%)
€63.51
03.11.18
03.11.18
€90.20
08.11.18
08.11.18
11.30%
08.11.18
08.11.18
Cognex Corp.
Start price
Target price
Perf. (%)
€40.30
14.10.18
14.10.18
€46.45
08.11.18
08.11.18
6.32%
08.11.18
08.11.18
Could be worthwhile Investment >10% per year
Jones Lang Lasalle
Start price
Target price
Perf. (%)
€130.62
11.09.18
11.09.18
€139.36
08.11.18
08.11.18
-0.10%
08.11.18
08.11.18
Spark Therapeutics
Start price
Target price
Perf. (%)
€51.46
09.08.18
09.08.18
€69.91
08.11.18
08.11.18
-21.82%
08.11.18
08.11.18
Nektar Therapeutics
Start price
Target price
Perf. (%)
€75.16
16.05.18
16.05.18
€90.20
08.11.18
08.11.18
-56.56%
08.11.18
08.11.18
Cornerstone Ondemand Inc.
Start price
Target price
Perf. (%)
€44.79
11.10.18
11.10.18
€48.71
08.11.18
08.11.18
10.07%
08.11.18
08.11.18
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€12.20
18.10.18
18.10.18
€14.88
07.11.18
07.11.18
16.41%
07.11.18
07.11.18
Jetblue Airways Corp.
Start price
Target price
Perf. (%)
€14.73
14.10.18
14.10.18
€16.24
07.11.18
07.11.18
10.69%
07.11.18
07.11.18
Select Medical Holdings
Start price
Target price
Perf. (%)
€16.87
11.09.18
11.09.18
€18.63
06.11.18
06.11.18
5.24%
06.11.18
06.11.18
Sanmina Corporation
Start price
Target price
Perf. (%)
€21.28
14.10.18
14.10.18
€26.16
02.11.18
02.11.18
9.73%
02.11.18
02.11.18
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€51.42
24.01.18
24.01.18
€86.41
01.11.18
01.11.18
-5.41%
01.11.18
01.11.18
Interactive Brokers Group Inc.
Start price
Target price
Perf. (%)
€53.60
07.01.18
07.01.18
€108.69
01.11.18
01.11.18
-5.62%
01.11.18
01.11.18
Ionis Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€40.27
11.10.18
11.10.18
€45.55
31.10.18
31.10.18
13.69%
31.10.18
31.10.18
Tilray Inc
Start price
Target price
Perf. (%)
€128.08
27.09.18
27.09.18
€351.78
29.10.18
29.10.18
-37.24%
29.10.18
29.10.18
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Standard Investments for future growth
Very capable Management